COPENHAGEN, Denmark, May 13, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced 2-year results from a post-hoc analysis of the Company’s Phase 3 PaTHway Trial demonstrating ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Impaired coronary flow reserve in patients with metastatic cancer treated with sunitinib. Impact of the chronic kidney disease epidemiology collaboration (CKD-EPI) equation for estimating renal ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Palopegteriparatide improved skeletal dynamics and renal ...
Dawn Ethier, a police officer in Ottawa, Canada, recalls how her life revolved around managing her 100-pill-a-day regimen. Her symptoms began 3 weeks after her thyroid surgery, but it took another 4 ...
Patient-derived parathyroid organoids (PTOs) could pave the way for future physiology studies and drug-screening applications, as shown in a new study. Patient-derived parathyroid organoids (PTOs) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results